Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

Sarnak MJ, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Marwick TH; Conference Participants.

J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. doi: 10.1016/j.jacc.2019.08.1017. Review.

2.

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ; Conference Participants.

Kidney Int. 2019 Oct;96(4):836-849. doi: 10.1016/j.kint.2019.06.025.

3.

The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.

Liu Q, Zhu LJ, Waaga-Gasser AM, Ding Y, Cao M, Jadhav SJ, Kirollos S, Shekar PS, Padera RF, Chang YC, Xu X, Zeisberg EM, Charytan DM, Hsiao LL.

J Mol Cell Cardiol. 2019 Sep 11;136:113-124. doi: 10.1016/j.yjmcc.2019.09.004. [Epub ahead of print]

4.

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.

Neuen BL, Young T, Heerspink HJL, Neal B, Perkovic V, Billot L, Mahaffey KW, Charytan DM, Wheeler DC, Arnott C, Bompoint S, Levin A, Jardine MJ.

Lancet Diabetes Endocrinol. 2019 Nov;7(11):845-854. doi: 10.1016/S2213-8587(19)30256-6. Epub 2019 Sep 5.

PMID:
31495651
5.

Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function.

Mavrakanas TA, Khattak A, Wang W, Singh K, Charytan DM.

Kidney Blood Press Res. 2019;44(5):1247-1258. doi: 10.1159/000502874. Epub 2019 Sep 2.

6.

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.

Mahaffey KW, Jardine MJ, Bompoint S, Cannon CP, Neal B, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Capuano G, de Zeeuw D, Greene T, Levin A, Pollock C, Sun T, Wheeler DC, Yavin Y, Zhang H, Zinman B, Rosenthal N, Brenner BM, Perkovic V.

Circulation. 2019 Aug 27;140(9):739-750. doi: 10.1161/CIRCULATIONAHA.119.042007. Epub 2019 Jul 11.

7.

Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.

Charytan DM, Natwick T, Solid CA, Li S, Gong T, Herzog CA.

Am J Kidney Dis. 2019 Oct;74(4):463-473. doi: 10.1053/j.ajkd.2019.04.018. Epub 2019 Jun 27.

PMID:
31255335
8.

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.

Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP; FOURIER Steering Committee and Investigators.

J Am Coll Cardiol. 2019 Jun 18;73(23):2961-2970. doi: 10.1016/j.jacc.2019.03.513. Erratum in: J Am Coll Cardiol. 2019 Aug 27;74(8):1162-1166.

PMID:
31196453
9.

Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.

Mavrakanas TA, Chatzizisis YS, Gariani K, Kereiakes DJ, Gargiulo G, Helft G, Gilard M, Feres F, Costa RA, Morice MC, Georges JL, Valgimigli M, Bhatt DL, Mauri L, Charytan DM.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):810-822. doi: 10.2215/CJN.12901018. Epub 2019 Apr 22.

PMID:
31010936
10.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.

PMID:
30990260
11.

Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study.

Tumlin JA, Roy-Chaudhury P, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM; MiD investigators and Committees.

BMC Nephrol. 2019 Mar 5;20(1):80. doi: 10.1186/s12882-019-1212-6.

12.

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA.

Diabetes Obes Metab. 2019 May;21(5):1199-1208. doi: 10.1111/dom.13642. Epub 2019 Mar 4.

PMID:
30672083
14.

Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.

Lima EG, Charytan DM, Hueb W, de Azevedo DFC, Garzillo CL, Favarato D, Linhares Filho JPP, Martins EB, Batista DV, Rezende PC, Hueb AC, Ramires JAF, Kalil Filho R.

Nephrol Dial Transplant. 2018 Dec 24. doi: 10.1093/ndt/gfy379. [Epub ahead of print]

PMID:
30590726
15.

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).

Vaduganathan M, White WB, Charytan DM, Morrow DA, Liu Y, Zannad F, Cannon CP, Bakris GL; EXAMINE Investigators.

Am J Cardiol. 2019 Feb 1;123(3):382-391. doi: 10.1016/j.amjcard.2018.10.035. Epub 2018 Nov 6.

PMID:
30477800
16.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, Hsu JY, Landis JR, Anderson AH, Hung AM, Mehrotra R, Sharma S, Weiner DE, Williams M, DiCarli M, Skali H, Kimmel PL, Kliger AS, Dember LM; Hemodialysis Novel Therapies Consortium.

Kidney Int. 2019 Apr;95(4):973-982. doi: 10.1016/j.kint.2018.08.034. Epub 2018 Nov 23.

PMID:
30473139
17.

Introduction: Cardiovascular Disease in Chronic Kidney Disease.

Charytan DM.

Semin Nephrol. 2018 Nov;38(6):541. doi: 10.1016/j.semnephrol.2018.08.008. No abstract available.

PMID:
30413249
18.

Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury.

Miller BLK, Garg P, Bronstein B, LaPointe E, Lin H, Charytan DM, Tilles AW, Parekkadan B.

Kidney Int Rep. 2018 Jun 2;3(5):1119-1127. doi: 10.1016/j.ekir.2018.05.009. eCollection 2018 Sep.

19.

The Authors Reply.

Charytan DM, Roy-Chaudhury P.

Kidney Int. 2018 Aug;94(2):430-431. doi: 10.1016/j.kint.2018.05.012. No abstract available.

PMID:
30031449
20.

End-Stage Renal Disease and Arrhythmic Death.

Weinrauch LA, Charytan DM, D'Elia JA.

JACC Clin Electrophysiol. 2018 Jul;4(7):975-976. doi: 10.1016/j.jacep.2018.04.018. No abstract available.

21.

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.

Mavrakanas TA, Khattak A, Singh K, Charytan DM.

BMC Nephrol. 2018 Jul 11;19(1):176. doi: 10.1186/s12882-018-0975-5.

22.

Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.

Herzog CA, Natwick T, Li S, Charytan DM.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1420-1426. doi: 10.1016/j.jcmg.2018.04.012. Epub 2018 Jun 13.

PMID:
29909107
23.

Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.

Roy-Chaudhury P, Tumlin JA, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, Charytan DM; MiD investigators and committees.

Kidney Int. 2018 Apr;93(4):941-951. doi: 10.1016/j.kint.2017.11.019. Epub 2018 Feb 12.

24.

Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.

Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):398-405. doi: 10.2215/CJN.05280517. Epub 2018 Jan 16.

25.

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.

Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V; CREDENCE study investigators.

Am J Nephrol. 2017 Dec 13;46(6):462-472. doi: 10.1159/000484633. [Epub ahead of print]

26.

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials.

Mavrakanas TA, Aurian-Blajeni DE, Charytan DM.

Swiss Med Wkly. 2017 Oct 12;147:w14507. doi: 10.4414/smw.2017.14507. eCollection 2017.

27.

Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.

Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Bibbo CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF.

Kidney Int. 2018 Feb;93(2):501-509. doi: 10.1016/j.kint.2017.07.025. Epub 2017 Oct 13.

28.

Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography.

Mavrakanas TA, Khattak A, Singh K, Charytan DM.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1624-1633. doi: 10.2215/CJN.04020417. Epub 2017 Aug 11.

29.

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, de Zeeuw D, Eckardt KU, McMurray JJV, Claggett B, Lewis EF, Pfeffer MA.

Am J Kidney Dis. 2017 Oct;70(4):522-531. doi: 10.1053/j.ajkd.2017.04.018. Epub 2017 Jun 7.

PMID:
28599901
30.

Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.

Stanifer JW, Charytan DM, White J, Lokhnygina Y, Cannon CP, Roe MT, Blazing MA.

J Am Soc Nephrol. 2017 Oct;28(10):3034-3043. doi: 10.1681/ASN.2016090957. Epub 2017 May 15.

31.

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT; American Society of Nephrology Dialysis Advisory Group.

Clin J Am Soc Nephrol. 2017 May 8;12(5):839-847. doi: 10.2215/CJN.08460816. Epub 2017 Mar 17. Review.

32.

A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.

Mendu ML, Ciociolo GR Jr, McLaughlin SR, Graham DA, Ghazinouri R, Parmar S, Grossier A, Rosen R, Laskowski KR, Riella LV, Robinson ES, Charytan DM, Bonventre JV, Greenberg JO, Waikar SS.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):228-236. doi: 10.2215/CJN.07170716. Epub 2017 Jan 24.

33.

Cardiovascular complications in chronic dialysis patients.

Mavrakanas TA, Charytan DM.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):536-544. Review.

34.

Spironolactone in Dialysis: What's Old Is New Again.

Charytan DM.

Am J Kidney Dis. 2016 Oct;68(4):512-514. doi: 10.1053/j.ajkd.2016.07.002. No abstract available. Erratum in: Am J Kidney Dis. 2017 Jan;69(1):162.

PMID:
27664475
35.

Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis.

Khattak A, Mandel EI, Reynolds MR, Charytan DM.

Am J Kidney Dis. 2017 Mar;69(3):350-357. doi: 10.1053/j.ajkd.2016.07.024. Epub 2016 Sep 16.

36.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC.

Kidney Int. 2016 Aug;90(2):411-421. doi: 10.1016/j.kint.2016.03.033. Epub 2016 Jun 1. Review. Erratum in: Kidney Int. 2017 Mar;91(3):758.

37.

Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, Tumlin JA; MiD Investigators and Committees.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):721-34. doi: 10.2215/CJN.09350915. Epub 2016 Jan 13.

38.

Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD.

Shah NR, Charytan DM, Murthy VL, Skali Lami H, Veeranna V, Cheezum MK, Taqueti VR, Kato T, Foster CR, Hainer J, Gaber M, Klein J, Dorbala S, Blankstein R, Di Carli MF.

J Am Soc Nephrol. 2016 Jun;27(6):1823-9. doi: 10.1681/ASN.2015030301. Epub 2015 Oct 12.

39.

Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden.

Charytan DM, Cinelli A, Zeisberg EM.

Fibrogenesis Tissue Repair. 2015 Jul 21;8:13. doi: 10.1186/s13069-015-0029-6. eCollection 2015.

40.

Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.

Khattak A, Charytan DM.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1107-9. doi: 10.2215/CJN.05340515. Epub 2015 Jun 25. No abstract available.

41.

Association of activated vitamin D use with myocardial fibrosis and capillary supply: results of an autopsy study.

Charytan DM, Padera RF, Helfand AM, Zeisberg EM.

Ren Fail. 2015 Jul;37(6):1067-9. doi: 10.3109/0886022X.2015.1040704. Epub 2015 May 8. No abstract available.

PMID:
25955707
42.

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD.

Am J Kidney Dis. 2015 Sep;66(3):429-40. doi: 10.1053/j.ajkd.2015.02.324. Epub 2015 Apr 29.

43.

Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Charytan DM, Fishbane S, Malyszko J, McCullough PA, Goldsmith D.

Am J Kidney Dis. 2015 Aug;66(2):196-205. doi: 10.1053/j.ajkd.2014.12.016. Epub 2015 Feb 26. Review.

44.

The effect of bicarbonate administration via continuous venovenous hemofiltration on acid-base parameters in ventilated patients.

Allegretti AS, Flythe JE, Benda V, Robinson ES, Charytan DM.

Biomed Res Int. 2015;2015:901590. doi: 10.1155/2015/901590. Epub 2015 Jan 8.

45.

Considerations and challenges in defining optimal iron utilization in hemodialysis.

Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S; Dialysis Advisory Group of the American Society of Nephrology.

J Am Soc Nephrol. 2015 Jun;26(6):1238-47. doi: 10.1681/ASN.2014090922. Epub 2014 Dec 26. Review.

46.

Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.

Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM.

Int J Cardiol. 2014 Sep;176(1):99-109. doi: 10.1016/j.ijcard.2014.06.062. Epub 2014 Jul 6.

47.

Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.

Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, Claggett B, Shah AM, Santos AB, Zile MR, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Solomon SD; PARAMOUNT Investigators.

Eur Heart J. 2014 Dec 21;35(48):3442-51. doi: 10.1093/eurheartj/ehu254. Epub 2014 Jun 30.

48.

Do implantable defibrillators help patients with CKD?

Charytan DM, Reynolds MR.

Am J Kidney Dis. 2014 Jul;64(1):4-6. doi: 10.1053/j.ajkd.2014.04.007. No abstract available.

49.
50.

Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis.

Vardi M, Yeh RW, Herzog CA, Winkelmayer WC, Setoguchi S, Charytan DM.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2213-20. doi: 10.2215/CJN.05130513. Epub 2013 Aug 22. Review.

Supplemental Content

Loading ...
Support Center